AcquisitionOct 21, 2026Pending
Hot🇺🇸 United States

American Oncology Network, Inc.Cencora, Inc.

Healthcare › Healthcare Services

Enterprise value$2.4BEnterprise value
AnnouncedOct 21, 2026
ConsiderationCash
StructureNot stated
RegionNorth America
Cross-borderNo
Contingent paymentYes

Overview

Cencora, Inc. agreed to acquire all of the equity interests in American Oncology Network, Inc. that it does not already own, valuing AON at an enterprise value of $2.4 billion, consisting of $2.3 billion at closing and CVRs of up to $100 million payable upon satisfaction of certain conditions, paid in cash.

Deal rationale

The document states the acquisition will expand Cencora's physician-led oncology MSO platform, add complementary capabilities and support community oncology practices across additional states.

AI-generated from the SEC filing
PendingHealthcare › Healthcare ServicesUnited StatesNorth America

Timeline

  1. AnnouncedOct 21, 2026

    Deal announced.

    Filing

Valuation and terms

Equity valueUndisclosed
Enterprise value$2.4BHeadline figure
ConsiderationCash

Advisors

Buy-side
CCitiJPJ.P. Morgan
Sell-side
MMoelis & Company

Parties

Target
American Oncology Network, Inc.
Headquarters
United States
Ticker
AONC
Acquirer
Cencora, Inc.
Headquarters
United States
Ticker
—